Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.11.4 extracted from

  • Levengood, M.R.; van der Donk, W.A.
    Use of lantibiotic synthetases for the preparation of bioactive constrained peptides (2008), Bioorg. Med. Chem. Lett., 18, 3025-3028.
    View publication on PubMedView publication on EuropePMC
Search for more literature for 3.4.11.4

Inhibitors

Inhibitors Comment Organism Structure
2,5-diamino-8-carbamimidamido-N-(4,8-diamino-5-methyl-1-methylidene-2,3,7-trioxononyl)-4-oxooctanamide potent inhibitor Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
erythrocyte
-
 Homo sapiens
-

Synonyms

Synonyms Comment Organism
tripeptidyl exopeptidase II
-
 Homo sapiens

Ki Value [mM]

Ki Value [mM] Ki Value maximum [mM] Inhibitor Comment Organism Structure
0.00002
-
 2,5-diamino-8-carbamimidamido-N-(4,8-diamino-5-methyl-1-methylidene-2,3,7-trioxononyl)-4-oxooctanamide
-
 Homo sapiens